Russell Investments »

Terns Pharmaceuticals shares owned by Russell Investments

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.2M 633k 6.56
2023-12-31 $1.8M 278k 6.49

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Prologis Common Stock (PLD)
Unitedhealth Group Common Stock (UNH)
Eli Lilly And Company Common Stock (LLY)
Equinix Common Stock (EQIX)
Welltower Common Stock (WELL)
Visa Common Stock (V)

View all positions for Russell Investments

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Vivo Capital
VR Adviser
Braidwell
Franklin Resources
Vanguard Group
Fairmount Funds Management
Millennium Management
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Decheng Capital
Russell Investments
Norges Bank Investment Management
Schonfeld Strategic Advisors

View all funds holding Terns Pharmaceuticals